Merck & Co Inc [MRK] stock prices are up 0.93% to $99.18 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The MRK shares have gain 1.60% over the last week, with a monthly amount glided 6.81%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Merck & Co Inc [NYSE: MRK] stock has seen the most recent analyst activity on November 24, 2025, when Wells Fargo upgraded its rating to an Overweight but kept the price target unchanged to $125 for it. Previously, Scotiabank started tracking the stock with Sector Outperform rating on November 13, 2025, and set its price target to $105. Berenberg downgraded its rating to a Hold but stick to its price target of $90 on September 17, 2025. Citigroup downgraded its rating to a Neutral but $84 remained the price target by the analyst firm on May 14, 2025. Cantor Fitzgerald started tracking with a Neutral rating for this stock on April 22, 2025, and assigned it a price target of $85. In a note dated February 18, 2025, Deutsche Bank downgraded a Hold rating on this stock and revised its target price from $128 to $105.
The stock price of Merck & Co Inc [MRK] has been fluctuating between $73.31 and $105.84 over the past year. Currently, Wall Street analysts expect the stock to reach $112.33 within the next 12 months. Merck & Co Inc [NYSE: MRK] shares were valued at $99.18 at the most recent close of the market. An investor can expect a potential return of 13.26% based on the average MRK price forecast.
Analyzing the MRK fundamentals
The Merck & Co Inc [NYSE:MRK] reported sales of 63.90B for trailing twelve months, representing a surge of 2.80%. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.36%, Pretax Profit Margin comes in at 0.34%, and Net Profit Margin reading is 0.3%. To continue investigating profitability, this company’s Return on Assets is posted at 0.17, Equity is 0.39 and Total Capital is 0.28. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.8.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 98.11 points at the first support level, and at 97.05 for the second support level. However, for the 1st resistance point, the stock is sitting at 100.19, and for the 2nd resistance point, it is at 101.20.
Ratios To Look Out For
It’s worth pointing out that Merck & Co Inc [NYSE:MRK]’s Current Ratio is 1.66. Also, the Quick Ratio is 1.44, while the Cash Ratio stands at 0.63. Considering the valuation of this stock, the price to sales ratio is 3.85, the price to book ratio is 4.76 and price to earnings (TTM) ratio is 13.12.
Transactions by insiders
Recent insider trading involved Downing Cristal N, Chief Comm. & Public Afrs Ofcr, that happened on Nov 10 ’25 when 7085.0 shares were sold. Officer, CRISTAL DOWNING completed a deal on Nov 10 ’25 to buy 7085.0 shares. Meanwhile, EVP,Chief Info&Digital Officer Williams David Michael sold 8614.0 shares on Nov 03 ’25.
